Subjective well being of patients receiving atypical antipsychotics as monotherapy or cotherapy with mood stabilizers - DIDAXI

Study identifier:NIS-NGR-DUM-2008/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Subjective well being of patients receiving atypical antipsychotics as monotherapy or cotherapy with mood stabilizers

Medical condition

Bipolar Disorder

Phase

-

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

540

Study type

Observational

Age

18 Years - 65 Years

Date

Study Start Date: 01 Apr 2008
Primary Completion Date: 01 Jul 2008
Study Completion Date: 01 Jul 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria